Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

Journal of Infection

Volumn 70, Issue 3, 2015, Pages 288-298

  Mirabelli, Carmen ^a,k   Surdo, Matteo ^a   Van Hemert, Formijn ^b   Lian, Zhichao ^c   Salpini, Romina ^a   Cento, Valeria ^a   Cortese, Maria Francesca ^a   Aragri, Marianna ^a   Pollicita, Michela ^a   Alteri, Claudia ^a   Bertoli, Ada ^d   Berkhout, Ben ^b   Micheli, Valeria ^e   Gubertini, Guido ^e   Santoro, Maria Mercedes ^a   Romano, Sara ^f   Visca, Michela ^f   Bernassola, Martina ^f   Longo, Roberta ^f   De Sanctis, Giuseppe Maria ^g   Trimoulet, Pascal ^h   Fleury, Hervè ^h   Marino, Nicoletta ⁱ   Mazzotta, Francesco ⁱ   Cappiello, Giuseppina ^f   Spanò, Alberto ^f   Sarrecchia, Cesare ^d   Zhang, Jing Maria ^c   Andreoni, Massimo ^d   Angelico, Mario ^d   Verheyen, Jens ^j   Perno, Carlo Federico ^a,d   Svicher, Valentina ^a   more..

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c YALE UNIVERSITY   (United States)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f SANDRO PERTINI HOSPITAL   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITÉ DE BORDEAUX   (France)

ⁱ SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^j UNIVERSITY HOSPITAL ESSEN   (Germany)

^k INSTITUT PASTEUR   (France)

more..

Author keywords

HBsAg; HBV; Serum HBV DNA; Virion maturation

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; BAYES THEOREM; CARBOXY TERMINAL SEQUENCE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IN VITRO STUDY; ITALY; MAJOR CLINICAL STUDY; MALE; PROBABILITY; VIRION; WILD TYPE; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HETEROZYGOTE; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; SITE DIRECTED MUTAGENESIS; VIROLOGY;

ADULT; BAYES THEOREM; CARRIER STATE; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; TRANSAMINASES;

EID: 84922774260     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.10.015     Document Type: Article

References (36)

1. Dandri M., Locarnini S. New insight in the pathobiology of hepatitis B virus infection. Gut 2012 May, 61(Suppl. 1):i6-i17. PubMed PMID: 22504921. Epub 2012/04/25. eng.
2. Gerlich W.H., Heermann K.H., Lu X. Functions of hepatitis B surface proteins. Arch Virol Suppl 1992, 4:129-132. PubMed PMID: 1450681. Epub 1992/01/01. eng.
3. Glebe D., Bremer C.M. The molecular virology of hepatitis B virus. Semin Liver Dis 2013 May, 33(2):103-112. PubMed PMID: 23749666. Epub 2013/06/12. eng.
4. Jeulin H., Velay A., Murray J., Schvoerer E. Clinical impact of hepatitis B and C virus envelope glycoproteins. World J Gastroenterol: WJG 2013 Feb 7, 19(5):654-664. PubMed PMID: 23429668. Pubmed Central PMCID: 3574591. Epub 2013/02/23. eng.
5. Bauer T., Weinberger K., Jilg W. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 2002 Feb, 35(2):455-465. PubMed PMID: 11826423. Epub 2002/02/05. eng.
6. Baumert T.F., Thimme R., von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol: WJG 2007 Jan 7, 13(1):82-90. PubMed PMID: 17206757. Epub 2007/01/09. eng.
7. Zuckerman J.N., Zuckerman A.J. Mutations of the surface protein of hepatitis B virus. Antivir Res 2003 Oct, 60(2):75-78. PubMed PMID: 14638401. Epub 2003/11/26. eng.
8. Iloeje U.H., Yang H.I., Chen C.J. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?. Liver Int 2012 Oct, 32(9):1333-1341. PubMed PMID: 22510145. Epub 2012/04/19. eng.
9. Tseng T.C., Liu C.J., Yang H.C., Su T.H., Wang C.C., Chen C.L., et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology 2013 Feb, 57(2):441-450. PubMed PMID: 22941922. Epub 2012/09/04. eng.
10. Ijaz B., Ahmad W., Javed F.T., Gull S., Hassan S. Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers. Virol J 2011, 8:86. PubMed PMID: 21352567. Pubmed Central PMCID: 3052190. Epub 2011/03/01. eng.
11. Svicher V., Cento V., Salpini R., Mercurio F., Fraune M., Beggel B., et al. Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development. Dig Liver Dis 2011 Dec, 43(12):975-983. PubMed PMID: 21831732. Epub 2011/08/13. eng.
12. Svicher V., Cento V., Bernassola M., Neumann-Fraune M., Van Hemert F., Chen M., et al. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antivir Res 2012 Jan, 93(1):86-93. PubMed PMID: 22086128. Epub 2011/11/17. eng.
13. Salpini R., Alteri C., Cento V., Pollicita M., Micheli V., Gubertini G., et al. Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. J Med Virol 2013 Jun, 85(6):996-1004. PubMed PMID: 23588725. Epub 2013/04/17. eng.
14. Cento V., Van Hemert F., Neumann-Fraune M., Mirabelli C., Di Maio V.C., Salpini R., et al. Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen. J Infect 2013 Oct, 67(4):303-312. PubMed PMID: 23796863. Epub 2013/06/26. Eng.
15. Zhang D., Ma S., Zhang X., Zhao H., Ding H., Zeng C. Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression. BMC Infect Dis 2010, 10:271. PubMed PMID: 20846420. Pubmed Central PMCID: 2949759. Epub 2010/09/18. eng.
16. Svicher V., Gori C., Trignetti M., Visca M., Micheli V., Bernassola M., et al. The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes. J Hepatol 2009 Mar, 50(3):461-470. PubMed PMID: 19041149. Epub 2008/12/02. eng.
17. van Hemert F.J., Zaaijer H.L., Berkhout B., Lukashov V.V. Mosaic amino acid conservation in 3D-structures of surface protein and polymerase of hepatitis B virus. Virology 2008 Jan 20, 370(2):362-372. PubMed PMID: 17935747. Epub 2007/10/16. eng.
18. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010 Apr, 5(4):725-738. PubMed PMID: 20360767. Pubmed Central PMCID: 2849174. Epub 2010/04/03. eng.
19. Kawabata T. MATRAS: a program for protein 3D structure comparison. Nucleic Acids Res 2003 Jul 1, 31(13):3367-3369. PubMed PMID: 12824329. Pubmed Central PMCID: 168987. Epub 2003/06/26. eng.
20. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004 Oct, 25(13):1605-1612. PubMed PMID: 15264254. Epub 2004/07/21. eng.
21. Black S.D., Mould D.R. Development of hydrophobicity parameters to analyze proteins which bear post- or cotranslational modifications. Anal Biochem 1991 Feb 15, 193(1):72-82. PubMed PMID: 2042744. Epub 1991/02/15. eng.
22. Stirk H.J., Thornton J.M., Howard C.R. A topological model for hepatitis B surface antigen. Intervirology 1992, 33(3):148-158. PubMed PMID: 1500275. Epub 1992/01/01. eng.
23. Bruss V., Ganem D. Mutational analysis of hepatitis B surface antigen particle assembly and secretion. J Virol 1991 Jul, 65(7):3813-3820. PubMed PMID: 2041095. Pubmed Central PMCID: 241412. Epub 1991/07/01. eng.
24. Jenna S., Sureau C. Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles. J Virol 1999 Apr, 73(4):3351-3358. PubMed PMID: 10074189. Pubmed Central PMCID: 104099. Epub 1999/03/12. eng.
25. Tedder R.S., Bissett S.L., Myers R., Ijaz S. The 'Red Queen' dilemma - running to stay in the same place: reflections on the evolutionary vector of HBV in humans. Antivir Ther 2013, 18(3 Pt B):489-496. PubMed PMID: 23792884. Epub 2013/06/26. eng.
26. Bruss V. Envelopment of the hepatitis B virus nucleocapsid. Virus Res 2004 Dec, 106(2):199-209. PubMed PMID: 15567498. Epub 2004/11/30. eng.
27. Chen P.J., Lai W.J., Wang C.J., Chen D.S. Hepatitis B surface antigen and large-form hepatitis delta antigen in HDV assembly: a further study. Prog Clin Biol Res 1993, 382:29-34. PubMed PMID: 8502694. Epub 1993/01/01. eng.
28. Khedive A., Norouzi M., Ramezani F., Karimzadeh H., Alavian S.M., Malekzadeh R., et al. Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study. J Viral Hepat 2013 Jul, 20(7):494-501. PubMed PMID: 23730843. Epub 2013/06/05. eng.
29. Chemin I., Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett 2009 Dec 1, 286(1):52-59. PubMed PMID: 19147276. Epub 2009/01/17. eng.
30. Warner N., Locarnini S. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008 Jul, 48(1):88-98. PubMed PMID: 18537180. Epub 2008/06/10. eng.
31. Mun H.S., Lee S.A., Kim H., Hwang E.S., Kook Y.H., Kim B.J. Novel F141L pre-S2 mutation in hepatitis B virus increases the risk of hepatocellular carcinoma in patients with chronic genotype C infections. J Virol 2011 Jan, 85(1):123-132. PubMed PMID: 20962085. Pubmed Central PMCID: 3014212. Epub 2010/10/22. eng.
32. Wang H.C., Huang W., Lai M.D., Su I.J. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 2006 Aug, 97(8):683-688. PubMed PMID: 16863502. Epub 2006/07/26. eng.
33. Tong M.J., Trieu J. Hepatitis B inactive carriers: clinical course and outcomes. J Dig Dis 2013 Jun, 14(6):311-317. PubMed PMID: 23433008. Epub 2013/02/26. eng.
34. Desmond C.P., Bartholomeusz A., Gaudieri S., Revill P.A., Lewin S.R. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir Ther 2008, 13(2):161-175. PubMed PMID: 18505168. Epub 2008/05/29. eng.
35. Mello F.C., Martel N., Gomes S.A., Araujo N.M. Expression of hepatitis B virus surface antigen containing Y100C variant frequently detected in occult HBV infection. Hepat Res Treat 2011, 2011:695859. PubMed PMID: 21331286. Pubmed Central PMCID: 3038563. Epub 2011/02/19. eng.
36. Biswas S., Candotti D., Allain J.P. Specific amino acid substitutions in the s protein prevent its excretion invitro and may contribute to occult hepatitis B virus infection. J Virol 2013 Jul, 87(14):7882-7892. PubMed PMID: 23658444. Pubmed Central PMCID: 3700177. Epub 2013/05/10. eng.